Clinical Trial Update: Safety and Effectiveness of tPA in Intra-abdominal Abscesses [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating the safety and effectiveness of tissue plasminogen activator (tPA) for intra-abdominal abscesses has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Abscess

Drugs mentioned

• tPA (alteplase) (alteplase)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Abscess | Phase 2, Phase 3 | Status: TERMINATED